Viewing Study NCT01313559


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-01-07 @ 1:41 PM
Study NCT ID: NCT01313559
Status: TERMINATED
Last Update Posted: 2025-04-30
First Post: 2011-03-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization: